The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...

Immunophenotyping is the identification and quantitation of heterogeneous populations of cells by multi-parameter flow cytometry using a panel of fluorescently-labelled antibodies that recognize ...

An international research team focused on aging reports that urolithin A at 1,000 mg per day shifted human immune profiles toward a more naive-like, less exhausted CD8 + state and increased fatty acid ...

HaemaLogiX earlier this week announced it has received TGA approval to commence a Phase 1 clinical trial of its KMCAR™ CAR-T cell therapy targeting multiple myeloma, marking a key milestone for the ...

Salk scientists discover that different people can have distinct responses to the same infection depending on how their genetics and life experiences have shaped their immune cell function. The ...